Levine Media Group
March 23, 2021
Amfora Raises $6 Million with Investment from Leaps by Bayer and Spruce Capital Partners
SAN FRANCISCO, March 23, 2021 (GLOBE NEWSWIRE) -- Amfora, Inc., a biotechnology company that is using gene editing to increase the protein density of soybean and other crops to fuel the plant-based protein revolution, announced that Leaps by Bayer and Spruce Capital Partners invested $6 million in its Series B financing round.
April 2, 2019
Amfora Licenses Gene Editing Technology
SAN FRANCISCO, April 02, 2019 -- Today Amfora, a biotechnology company, announced it has reached a non-exclusive research and commercial license agreement with Corteva Agriscience™, the Agriculture Division of DowDuPont™, and the Broad Institute of MIT and Harvard. Through the agreement, Amfora will use intellectual property covering CRISPR-Cas9 and related gene editing tools to develop a portfolio of gene-edited crops with increased protein content.
January 3, 2019
United Soybean Board Awards Grant to Amfora to Increase the Protein Content of U.S. Soy
SAN FRANCISCO, Jan. 03, 2019 -- Amfora, a biotechnology company that is applying gene editing to sustainably feed the planet, announced that it has received a grant from the United Soybean Board that the company will use to develop soybean varieties with increased protein content.
June 28, 2018
Amfora Unveils Broad Initiative to Develop Crops with Enhanced Protein Content for Food and Feed
SAN FRANCISCO, June 28, 2018-- Amfora Inc., a biotechnology company committed to improving the nutritional content of food and feed crops, today unveiled a major new program to develop crops with enhanced protein.
April 12, 2017
Amfora Raises $5 Million in Series A Venture Round
Biotech company will use the funding to accelerate the development of crops for improved human and animal nutrition
SAN FRANCISCO - Apr 12, 2017 - Amfora Inc., a biotech start-up focused on developing crops with enhanced nutritional content, today announced the closing of a Series A financing. San Francisco-based Spruce Capital, co-manager of the MLS Fund II, led the round, which included participation from The Commonwealth Scientific Industrial Research Organization (CSIRO), the globally renowned Australian-based national science agency.
March 24, 2021
Amfora gets $6m Series B injection from Bayer, Spruce Capital to increase protein in crops
US foodtech startup Amfora has raised $6 million in Series B funding from San Francisco VC firm Spruce Capital Partners and Leaps by Bayer, the corporate venture arm of German life sciences giant Bayer.
August 14, 2020
Gene Editing Meets Supermarket Shelves
Many customers want to eat better, and CPG companies are constantly introducing new products to align with every new fad and trend out there, from keto to super carb and everything in between.
April 19, 2019
Amfora Licenses Gene Editing Tech in High-Protein Soy Work
Amfora signs agreement to use Cas9 in its ongoing work to generate a high-protein soybean variety for use as an aquafeed ingredient, says CEO
High protein soybean meal for aquaculture could soon be a commercially reality, as US biotech company Amfora embarks on a program to apply its patented gene editing technology to develop crops with an enhanced protein content.
Read the story in Feed Navigator
June 8, 2017
From bioengineered crops to crowdsourced farm info, ag-bio startups seed the Bay Area
In a world where arable land and potable water are becoming more scarce and harsh climate changes more common, many investors are looking to the emerging field of ag-bio to feed a growing global population.
Read the story in the San Francisco Business Times
April 17, 2017
Biotech Raises $5M to Improve Forage Feed Crops
Amfora is focusing its forage research on improving the energy level of feed crops destined for dairy feed, executive says
Read the story in Feed Navigator